FDA meets with NIDA to discuss Ibogaine

Copyright 1993 Federal Information Systems Corporation
FNS DAYBOOK

AUGUST 25, 1993, WEDNESDAY

LANGUAGE: ENGLISH

LOAD-DATE-MDC: August 23, 1993

EDITION: FINAL

SECTION: FEDERAL AGENCIES AND DEPARTMENTS

LENGTH: 386 words

HEADLINE: EVENT: THE FOOD AND DRUG ADMINISTRATION

TIME: 9:00 am

BODY:
SUBJECT: (FDA) MEETING. The Food and Drug Administration’s Drug Abuse Advisory Committee meets to discuss information from the National Institute on Drug Abuse regarding the potential toxicity and benefits of Ibogaine, an alkaloid for drug addiction therapy. The drug, made from a West African root, has received media attention recently due to clinical trials outside the United States that show it significantly reduces and even eliminates cravings for heroin and cocaine in addicts. The committee meets in closed session from noon to 5 p.m.

LOCATION: Holiday Inn, 8777 Georgia Ave., Silver Spring, Md., Plaza Ballroom –August 25

CONTACT: Isaac Roubein, 301-443-3741, or the hotel, 301-589-0800

Print Friendly

Comments are closed